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Molecular Genetics of Atrial Fibrillation
Chia-Ti Tsai, MD, PHD,* Ling-Ping Lai, MD, PHD,*† Juey-Jen Hwang, MD, PHD,*
Jiunn-Lee Lin, MD, PHD,* Fu-Tien Chiang, MD, PHD*‡
Taipei, Taiwan
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. There is genetic predisposition for the
development of AF. Recently, by linkage analysis, several loci have been mapped for monogenetic AF, including
11p15.5, 21q22, 17q, 7q35–36, 5p13, 6q14–16, and 10q22. Some of these loci encode for subunits of potas-
sium channels (KCNQ1, KCNE2, KCNJ2, and KCNH2 genes), and the remaining are yet unidentified. All of the
known mutations are associated with a gain of function of repolarization potassium currents, resulting in a
shortening of action potential duration and atrial refractory period, which facilitate multiple re-entrant circuits in
AF. In addition to familial AF, common AF often occurs in association with acquired diseases such as hyperten-
sion, valvular heart disease, and heart failure. By genetic association study, some genetic variants or polymor-
phisms related to the mechanism of AF have been found to be associated with common AF, including genes
encoding for subunits of potassium or sodium channels, sarcolipin gene, renin-angiotensin system gene,
connexin-40 gene, endothelial nitric oxide synthase gene, and interleukin-10 gene. These observations suggest
that genes related to ionic channels, calcium handling protein, fibrosis, conduction and inflammation play impor-
tant roles in the pathogenesis of common AF. The complete elucidation of genetic loci for common AF is still in
its infancy. However, the availability of genomewide scans with hundreds or thousands of polymorphisms has
made it possible. However, challenges and pitfalls exist in association studies, and consideration of particular
features of study design is necessary before making definite conclusions from these studies. (J Am Coll Cardiol
2008;52:241–50) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.02.072h
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ctrial fibrillation (AF) is the most common sustained
rrhythmia in clinical practice and therefore represents a
ajor public health problem. The majority of patients with
F have underlying heart disease, such as valvular heart
isease, hypertension, or left ventricular dysfunction. How-
ver, other patients remain in sinus rhythm despite the
resence of significant valvular diseases and/or left ventric-
lar dysfunction. Importantly, some patients develop AF in
he absence of any known risk factor (lone AF). Taken
ogether, this suggests there is also a genetic predisposition
or the development of AF. A recent Framingham Heart
tudy of 2,243 participants showed that the relative risk of
F was increased by 85% in individuals with at least 1
arent with a history of AF (1).
According to the patterns of heredity, AF could be
ategorized into 2 major types. The first type is familial AF
ith a mendelian hereditary pattern, and the second type is
onfamilial AF. Familial AF is a monogenetic disorder and
s often identified as AF being present in many members of
he same family. Although uncommon, familial AF some-
imes occurs in the setting of other inherited (structural)
rom the *Division of Cardiology, Department of Internal Medicine, †Institute of
harmacology, and ‡Department of Laboratory Medicine, National Taiwan Univer-
ity Hospital, Taipei, Taiwan.e
Manuscript received November 27, 2007; revised manuscript received January 29,
008, accepted February 19, 2008.eart diseases (e.g., in association with dilated or hypertro-
hic cardiomyopathy) (2–5).
Unlike familial AF, in which genetic factor is the major
ontributing factor, nonfamilial AF typically occurs in
ssociation with underlying cardiovascular disease. There-
ore, genetic factors, interacting with nongenetic or envi-
onmental factors, contribute to the risk of nonfamilial AF.
s such, nonfamilial AF is also called complex-trait, mul-
ifactorial, or multigenetic AF. Nonfamilial AF is more
ommonly encountered in clinical practice than familial AF.
n the present review, we present recent work on genetic
tudies of familial and nonfamilial AF separately, because
he molecular mechanisms and methods used to study the
enetic basis of these 2 distinct types of AF are different
Table 1). Familial AF in the setting of inherited (struc-
ural) heart disease is not the subject of the present review.
eneral Mechanisms of AF
he underlying mechanisms of AF are complex. Multiple
apidly discharging foci, a focal source with fibrillatory
onduction (6,7), or multiple re-entrant circuits (8) have
een proposed to explain the maintenance of AF. At
resent, both the focal source and the multiple re-entrant
ircuit theories are the generally accepted hypotheses to
xplain AF.
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Genetics of Atrial Fibrillation July 22, 2008:241–50In the multiple re-entry the-
ory, the stability of AF is deter-
mined by the number of wavelets
in the atria (8). The wavelength,
which is the distance traveled by
an impulse during 1 refractory
period, is the basal unit of a
traveling wavelet, and can be cal-
culated from the product of the
refractory period and conduction
velocity (7). Therefore, the
shorter the wavelength, the more
wavelets in the atria, and thus
AF will be more stable (8). Con-
sequently, the functional effects
of genes that determine changes in
refractory period or conduction
velocity will affect the wave-
length of the traveling wavelet,
and therefore the stability of AF.
Changes of the electrophysiolog-
cal properties after repeated episodes of AF, such as the
hortening of the atrial refractory period, are referred to as
lectrical remodeling.
Triggers are required for the initiation of AF and include
trial ectopic foci originating from the junctions between
he left atrium and the pulmonary veins or the atria itself.
roposed mechanisms initiating these atrial ectopic foci
nclude increased automaticity, afterdepolarization, and
icrore-entry. These triggers may initiate multiple re-
ntrant circuits in the presence of conduction blocks in the
tria. Spatial inhomogeneity of atrial refractoriness plays an
mportant role in creating conduction block. Spatial inho-
ogeneity of atrial refractoriness typically occurs in associ-
tion with structural remodeling of the atrium. Therefore,
he downstream functional effects of genes that contribute
o the mechanisms of increased automaticity, afterdepolar-
zation, or structural remodeling will also promote AF.
The mechanisms triggering and maintaining AF overlap.
or example, a rapidly discharging focus could both initiate
nd maintain AF. Structural changes of the atria may
ecrease the conduction velocity, resulting in decreased
avelength (the product of the refractory period and con-
uction velocity) and thus more wavelets in the atria, which
re involved in maintenance of AF. Structural changes of
he atria may also create conduction blocks and thus initiate
ultiple re-entrant circuits and AF.
In the early stage of AF, patients may present with
aroxysmal AF due to intermittent episodes of the atrial
ctopic foci. After repeated episodes of AF, the atria
ndergo electrical and structural remodelings, which facili-
ate the maintenance of AF. Finally, AF undergoes self-
erpetuation and becomes persistent or chronic. The whole
pectrum of AF can be observed in both familial and
Abbreviations
and Acronyms
AF  atrial fibrillation
CI  confidence interval
IKr  rapidly activating
delayed rectifier potassium
current
IKs  slowly activating
delayed rectifier potassium
current
IK1  inward rectifier
potassium current
LQTS  long QT syndrome
OR  odds ratio
RAS  renin-angiotensin
system
SLN  sarcolipin
SNP  single nucleotide
polymorphismonfamilial AF. wamilial AF
inkage analysis was used in most of the genetic studies for
onogenetic AF. The success of this method depends on
he establishment of a large pedigree as well as a clear
dentification of the phenotypes. Although a mutated gene
ound in one family may not be present in another family or
n patients with multifactorial or multigenetic AF, identi-
ying the responsible genes and investigating the functional
ignificance of the mutation will contribute significantly to
he understanding of the pathogenesis of AF.
nknown gene. Brugada et al. (9) first reported 3 families
ith autosomal dominant AF. Linkage analysis revealed
0q22–24 as the genetic locus in these families, although
he exact gene responsible remains unclear. A candidate
ene approach has been applied to the 10q22–24 region.
ne of the possible candidate genes was the DLG5 (discs,
arge [Drosophila] homolog 5) gene, a member of the
AGUK (membrane-associated guanylate kinase) family
hich mediates intracellular signaling. However, this gene
as been excluded as the responsible gene in these families
10). Efforts on positional cloning of other genes in this
egion are still ongoing.
Darbar et al. (11) also reported 4 multigeneration
amilies with autosomal dominant AF. However, geno-
yping of these families with deoxyribonucleic acid
DNA) markers spanning the chromosome 10q22–24
egion excluded linkage of AF to this locus (11).
Ellinor et al. (12) investigated 34 members in a family
ith familial AF. They found a logarithm of the odds score
f 3.63 at a marker at 6q14–16. The exact gene responsible
emains unknown.
CNQ1 gene. Chen et al. (13) studied a 4-generation
hinese family with autosomal dominant AF. The locus
as mapped to chromosome 11p15.5, and the KCNQ1
ene, which encodes for the -subunit of the cardiac slow
elayed rectifier potassium channel (IKs) (14), was identi-
ed as the responsible gene. This gene is the same as the
rst genetic locus for congenital long QT syndrome (LQT1)
14). Sequencing studies revealed a missense mutation at
ucleotide 418 from adenine to guanine. This missense
utation results in a change of amino acid from serine to
lycine at position 140 (S140G). In vitro coexpression of
his mutant gene with minK gene (15) (LQT5, the
-subunit of the cardiac IKs channel) in COS7 cells
emonstrated that this mutation causes a significant in-
rease in IKs current density. Therefore, a mutation in
CNQ1 with gain-of-function effect is responsible for
amilial AF in this Chinese family. Interestingly, other
utations in the same gene with loss-of-function effect have
een reported to be responsible for congenital LQTS (13).
t is speculated that a gain of function on IKs results in a
hortening of action potential duration and atrial refractory
eriod, which facilitates multiple re-entrant circuits and
avelets in AF (8,17). This observation implies that IKs
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July 22, 2008:241–50 Genetics of Atrial Fibrillationlays an important role in AF and that IKs-blocking agents
ight be an effective way to treat AF in some patients.
CNE2 gene. The same group also identified a locus
esponsible for familial AF on 21q22 encoding for another
otassium channel subunit, KCNE2 (18). The mutation
nvolved a cytosine to thymine transition at nucleotide 79 of
he gene for KCNE2. This resulted in an arginine to
ysteine substitution at residue 27 (R27C). The KCNE
ene family encodes small proteins that function as
-subunits of several voltage-gated cation channels (19).
CNE2 encodes for MiRP1, the putative -subunit of the
apid component of the delayed rectifier current (IKr) (16)
nd the KCNQ1-KCNE2 channel, which produces back-
round potassium current. Functional analyses also revealed
gain-of-function effect, which may result in a shortening
f the action potential duration and facilitate multiple
avelets and perpetuation of AF (8,17).
CNJ2 gene. Because overexpression of the wild-type
ir2.1 in the mouse induced AF (20), Xia et al. (21) studied
0 Chinese AF kindreds for a mutation in KCNJ2, which
ncodes for the Kir2.1 channel and mediates an inward
ectifier potassium current in the heart (IK1). A valine-to-
soleucine mutation at position 93 (V93I) of the Kir2.1 gene
as found in all affected members in one kindred. Func-
ional analysis of the V93I mutant also demonstrated a
ain-of-function consequence on the Kir2.1 current, which
gain may result in a shortening of the action potential
uration and favor multiple re-entrant circuits and wavelets
n AF (8,17). Increased expression of the Kir2.1 channel has
lso been found in atrial samples from patients with com-
on AF (22–25).
CNH2 gene. Recently, Hong et al. (26) identified a
amily with short QT syndrome in whom 3 members
resented with AF. The 17-year-old proband presented
ith paroxysmal AF. They found that the KCNH2 gene
xhibited a missense mutation at nucleotide 1764 with a
ytosine to guanine substitution, resulting in a lysine to
sparagine mutation at residue 588 (N588K). KCNH2
ncodes for the HERG protein, the -subunit of the cardiac
Kr channel, which also contributes to the repolarization of
he cardiac action potential. Programmed electrical stimu-
ation was performed in all affected members with N588K
utation, which revealed a remarkably short atrial and
entricular refractory period, and inducibility of atrial and
entricular fibrillation. The mutation therefore confers a
ain-of-function of IKr, with a shortening of the effective
trial refractory period.
In summary, all identified genes discussed thus far encode
or subunits of potassium channels and the mutations confer
gain of function, shortening the atrial action potential
uration and the atrial effective refractory period, therefore
romoting an ideal substrate for multiwavelet re-entry.
owever, most of the AF families with identified potassium
hannel mutations are from the Chinese population
12,18,20). Recently, Ellinor et al. (27) screened for muta-
ions in KCNJ2 and KCNE15 genes in 96 probands of AF ramilies from the Caucasian population. No mutations were
ound in these genes. Therefore, the potassium channel
ene mutation may not be universal for familial AF in all
thnic populations, although other important potassium
hannel genes, such as the KVLQT1 and HERG genes, were
ot screened. Furthermore, the manifestation of a mutation
ay also be affected by environmental factors. Recently,
14C missense mutation of the KCNQ1 gene was identified
n one AF family with a high prevalence of hypertension.
ll of the affected members had hypertension. Patch-clamp
tudies of wild-type or R14C KCNQ1 coexpressed with
CNE1 in Chinese hamster ovary cells showed no signifi-
ant differences between wild-type and mutant channel
inetics at baseline. After exposure to hypotonic solution to
licit cell swelling/stretch, mutant channels showed a
arked increase in current and altered channel kinetics (28).
hese data suggest that the R14C KCNQ1 mutation alone
s insufficient to cause AF. A model of a “second hit,” such
s an environmental factor like hypertension, which pro-
otes atrial stretch, along with the inherited defect in ion
hannel kinetics (the “first hit”), was proposed to explain
his phenomenon.
Nevertheless, the above observations demonstrate that
otassium channels play a very important role in the
athogenesis of AF in patients without underlying heart
isease and provide specific targets for the development of
ovel drug therapy to treat AF.
onfamilial AF
his form of AF is distinct from familial AF in terms of its
linical presentation, underlying genetic loci and molecular
echanisms. To find the genetic susceptible loci for com-
on AF, a genetic association study is commonly used
nstead of linkage analysis. The concept of genetic associa-
ion is based on the premise that the frequencies of the
ariants within or close to the susceptibility gene(s) are
ifferent between the diseased population and the general
opulation. Furthermore, these genetic variants encode
roteins with only mild or minimal functional change and
ot marked loss or gain of function (such as those encoded
y mutant genes in familial AF). This kind of genetic
ariant is called a polymorphism (instead of mutation).
hen the variant involves only a nucleotide change, it is
alled a single nucleotide polymorphism (SNP).
A candidate gene approach is commonly used to test the
ssociation of specific genetic variants or SNPs with the
isease. This approach is performed by choosing candidate
enes which encode for proteins that have been determined
o be mechanistically linked to the pathogenesis of the
isease. This approach is different from the so-called
enome-wide approach, in which all genes or makers from
he whole genome are tested without an a priori assumption
egarding which genes are possibly responsible.
Genetics of AF
Table 1 Genetics of AF
Functions Mode GenBank/dbSNP No. of Cases Race AF Type Method UHD Reference(s)
Familial AF
No locus and gene identified
FAF1–4 ? AD — 4 families Caucasian PAF Screen Nil 11
Locus identified
10q22–24 ? AD — 3 families Caucasian CAF Link Nil 9
6q14–16 ? AD — 1 family Caucasian PAF Link Nil 12
Gene identified
KCNQ1 S140G -subunit of IKs (KVLQT1)
Gain of function
AD NP_000209.2:p.S140G
NM_000218.2:c.418AG
1 family Chinese CAF Link Nil 13
KCNQ1 R14C -subunit of IKs (KVLQT1)
Gain of function under stretch
AD NP_000209.2:p.R14C
NM_000218.2:c.40CT
50 families Caucasian PAF Screen HTN 28
KCNE2 R27C -subunit of KCNQ1-KCNE2
Gain of function
AD NP_751951.1:p.R27C
NM_172201.1:c.79CT
2 families Chinese PAF Link Nil 18
KCNJ2 V93I -subunit of IK1 (Kir2.1)
Gain of function
AD NP_000882.1:p.V93I
NM_000891.2:c.277GA
30 kindreds Chinese PAF Screen Nil 21
KCNH2 N588K -subunit of IKr (HERG)
Gain of function
AD NP_000229.1:p.N588K
NM_000238.2:c.1764CA
1 family Caucasian PAF Screen Nil 26
Nonfamilial AF
Candidate gene approach
Ionic channels/calcium handling proteins
KCNE1 (A112G or S38G) -subunit of IKs (KVLQT1)
Decreased function
Poly rs1805127 or rs17846179 108 case-control pairs Taiwanese PAFCAF Asso VHD, CHF, HTN 29,31
G protein beta(3)-subunit (C825T) Regulatory protein of IK1
Decreased function
Poly rs5443 291 cases/
292 controls
Caucasian PAFCAF Asso HTN 34
SCN5A (A1867G or H558R) -subunit of INa
Decreased function
Poly rs1805124 157 cases/
314 controls
Caucasian PAFCAF Asso Nil 36
Sarcolipin (G-65C) Inhibitor of SERCA Poly rs583362 147 cases/
92 controls
Caucasian PAFCAF Screen Nil 37
Functional significance unknown Asso
Nonionic channels/calcium handling proteins
Renin-angiotensin system AngII biosynthesis pathway 250 case-control pairs Taiwanese PAFCAF Asso VHD, CHF, HTN 38,42
(ACE I/D) AngII augments ICaL Poly rs1799752
(AGT G-6A, A-20C, G-152A, and G-217A) Poly rs699 (M235T)
and rs4762 (T174M)
(AT1R A1166C) Poly rs1799752
Continued on next page
244
Tsaietal.
JACC
Vol.52,No.4,2008
Genetics
ofAtrialFibrillation
July22,2008:241–50
Continued
Table 1 Continued
Functions Mode GenBank/dbSNP No. of Cases Race AF Type Method UHD Reference(s)
Cx40 Cx40 gene promoter haplotype
(44A/71G and 44G/71A) Decreased promoter function Poly — 173 cases/
232 controls
Taiwanese PAFCAF Asso VHD, CHF, HTN 49
(P88S, M163V, G38D, and A96S) Mutant Cx40 protein S. Mut — 15 cases Caucasian PAF Screen Nil 51
Impaired intracellular transport
eNOS Antiinflammatory pathway
(T-786C, interaction with KCNE1 S38G) Functional significance unknown Poly — 331 cases/
441 controls
Caucasian PAFCAF Asso HTN, CHF 31
(G894T or E298D) Poly rs1799983 340 patients with CHF
(51 AF/289 nonAF)
Caucasian PAFCAF Asso CHF 52
MMP2 (C-1306T) and Inflammatory and fibrotic
pathways
Poly — 196 cases/
873 controls
Japanese CAF Asso Nil 53
IL10 (A-592C) Functional significance unknown Poly rs1800872
Genome-wide scan
Ilummina Hap300 BeadChip SNPs Underlying gene uncertain 2,801 cases/
17,714 controls
(Iceland)
Caucasian AFAFL Asso Stroke, HTN 56
rs2200733 Nearby genes PITX2 and ENPEP Poly rs2200733 143 cases/
738 controls (Sweden)
rs10033464 Morphogenesis of the heart
(PITX2)
Poly rs10033464 636 cases/
804 controls (U.S.)
Breakdown of AngII (ENPEP) 333 cases/
2,836 controls
Chinese Stroke, diabetes
mellitus
ACE  angiotensin-converting enzyme; AD  autosomal dominant; AF  atrial fibrillation; AFL  atrial flutter; AGT angiotensinogen; AngII angiotensin II; Asso association study; AT1R angiotensin type 1 receptor; CAF chronic atrial fibrillation; CHF congestive heart
failure; Cx40 connexin 40; eNOS endothelial nitric oxide synthase; FAF familial atrial fibrillation; HTN hypertension; ICaL L-type calcium current; I/D insertion/deletion; IKr rapidly activating delayed outward rectifier potassium channel; IKs slowly activating
delayed outward rectifier potassium channel; IK1  inward rectifier potassium channel; IL10  interleukin-10; link  linkage analysis; MMP2 matrix metalloproteinase 2; PAF  paroxysmal atrial fibrillation; poly  polygenetic; SERCA  sarcoplasmic reticulum calcium
ATPase; SLN  sarcolipin; S. Mut  somatic mutation; UHD  underlying heart disease; VHD  valvular heart disease.
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Genetics of Atrial Fibrillation July 22, 2008:241–50enes of potassium channel subunits and regulatory
roteins. Lai et al. (29) first investigated the association
etween minK gene (KCNE1) polymorphism and non-
amilial AF in the Taiwanese population. The polymor-
hism involves an adenine to guanine transition at position
12 in the KCNE1 gene, resulting in a glycine to serine
mino acid substitution at position 38 of the minK peptide
S38G). This study also used a candidate gene approach,
nd minK gene was selected because it is the -subunit of
he cardiac IKs (15,30). In this study, the authors used an
ndividually matched design to decrease the effects of
onfounding factors. The case and control groups were
ndividually matched regarding age, gender, left ventricular
ysfunction, and significant valvular heart disease. These
arameters are known nongenetic risk factors for the devel-
pment of AF. There were a total of 108 patients with
F and 108 matched control subjects. The results demon-
trated that the minK 38G allele was associated with an
ncreased risk for AF. The minK 38G allele frequency was
ignificantly higher in the AF group than in the control
roup (76.4% vs. 63.0%; p  0.01), and patients with at
east 1 38G allele had a higher risk to develop AF (odds
atio [OR]: 1.8; 95% confidence interval [CI]: 1.2 to 2.7;
 0.0046).
Recently Fatini et al. (31) studied 331 patients with
onvalvular AF and 441 control subjects from the Cauca-
ian population and similarly found that minK gene 38G
llele was associated with AF (dominant model: OR: 1.73;
5% CI: 1.19 to 2.53; p 0.004; recessive model: OR: 1.59;
5% CI: 1.15 to 2.27; p  0.006). These results are
nteresting, and indicate that a polymorphism (29) and a
utation (12) on genes (KCNE1 and KCNQ1, respectively)
ncoding different subunits of the same ionic channel (IKs)
ay be responsible for the development of nonfamilial and
amilial AF, respectively. From these results it is also
mplied that familial and nonfamilial AF may share some
ommon mechanism.
A functional study of this minK (KCNE1) gene polymor-
hism was performed by another group (32). Ehrlich
t al. (32) reported a smaller IKs current density when 38G
inK was coexpressed with KVLQT1 in Chinese hamster
vary cells, prolonging simulated atrial action potential
uration and favoring occurrence of early afterdepolariza-
ions under some conditions. This result is contrary to that
eported by Chen et al. (12), where a gain of function of IKs
rom a mutation in the KCNQ1 gene was found to cause
amilial AF. However, it has also been reported that mice
ith deletion of the KCNE1 protein (KCNE1/; com-
lete loss of function) have spontaneous episodes of AF
espite normal atrial size and structure (33). KCNE1/
ice displayed unexpectedly shortened atrial action poten-
ials and had spontaneous episodes of AF. Chromanol 293B
a KCNQ1 blocker) sensitive potassium currents were also
ignificantly increased in atrial cells from KCNE1/ mice.
urthermore, cells expressing KCNQ1 alone displayed
arked current accumulation at a fast rate (10 Hz), which was not found in cells expressing KCNQ1 and KCNE1.
hese results indicate that multiple factors related to genetic
ariations of IKs subunit genes may underlie the molecular
echanism of AF. Further functional studies are warranted
o find alternative explanations for these contradictory
esults.
Schreieck et al. (34) reported an association between
825T polymorphism in the coding region of the
-protein 3-subunit (GNB3) gene and nonfamilial AF.
his polymorphism has been reported to affect atrial inward
ectifier potassium currents, because it has been shown that
atients with TT genotype have a higher IK1 current
ensity in the right atrium (35). There were 291 AF patients
nd 292 control patients in the study and both groups had
similar profile of cardiovascular risk factors (hypertension,
ypercholesterolemia, and high body mass index). Patients
ith coronary heart disease, valvular heart disease, or car-
iomyopathy were excluded from the study. They found
hat the TT genotype was associated with a 54% decrease in
he adjusted risk (OR: 0.46; 95% CI: 0.24 to 0.87; p 0.02)
or the occurrence of AF. Again, this result is contrary to the
esult reported by Xia et al. (21), where a gain of function of
K1 from a mutation in the KCNJ2 gene was found to cause
amilial AF. Nevertheless, these results demonstrate that
lternation of the inward rectifier potassium channel current
ontributes not only to familial AF (21), but also to
onfamilial AF (34). It is also possible that other than the
lectrophysiological mechanisms, many of the genetic vari-
tions or mutations (including ion channel mutations)
nduce secondary morphologic, signaling, and/or mechani-
al changes that predispose to AF.
enes of sodium channel subunits. The cardiac sodium
hannel (SCN5A) is a target for the treatment of arrhyth-
ias (class I antiarrhythmic drugs). Recently, Chen et al.
36) studied 157 patients with early-onset AF who lacked
raditional risk factors and 314 matched control subjects.
hey found an association between a common loss-of-
unction H558R amino acid polymorphism of the SCN5A
ene and nonfamilial lone AF. The R558 allele was more
ommon in AF patients than in control subjects (30% vs.
1%; p  0.002), conferring an OR for AF of 1.6 (95% CI:
.2 to 2.2). It is speculated that decreased sodium channel
urrent may result in a slower rate of the upstroke of phase
depolarization, a decreased conduction velocity, and thus
shorter wavelength of a conduction impulse (7). As
entioned, the shorter the wavelength, the more wavelets in
he atria, and AF will be more stable (8,17).
ene of the sarcoplasmic reticulum calcium ATPase
SERCA2) regulatory protein. Sarcolipin (SLN) is a 31-
mino acid protein, a homologous peptide of phospholam-
an. Like phospholamban, SLN is an effective inhibitor of
ERCA2a. However, it is more highly expressed in atrial
yocytes compared with phospholamban (37). The associ-
tion study between the SLN gene variation and AF was
rst shown by Nyberg et al. (38). The coding region of SLN
as screened for mutations using single-strand conforma-
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NA from 147 patients with AF and 92 control subjects.
berrant conformers were sequenced. No mutations or
olymorphisms were found in the coding sequence. A
olymorphism, a guanine-to-cytosine transversion at posi-
ion 65 in the promoter region was found, with a G allele
requency of 0.48. A significant difference in genotype
istribution of this polymorphism (G-65C) was found
etween the AF group and control subjects (CC genotype:
5% in control subjects and 32% in AF patients; p 0.011),
lthough no significant difference of allele frequency was
ound. No promoter functional assay was performed for this
olymorphism. Studies involving larger series of patients
rom different ethnic populations are warranted to confirm
he role of SLN gene variations in AF.
enin-angiotensin system (RAS) genes. Our group (39)
lso used a risk-factor matched design and reported an
ssociation between genetic polymorphisms within genes of
he RAS and nonfamilial AF. The choice of RAS genes was
ased on recent findings that AF is associated with the
ctivation of RAS in the atria of humans (40) and animal
odels of AF (41,42). Angiotensin II induces atrial fibrosis
41–43), which may result in an increase in conduction
eterogeneity, conduction block, and facilitation of re-entry.
ompared with a previous study with a similar risk-factor
atched design (29), the case number and number of
enetic polymorphisms in this study were substantially
ncreased (250 case-control pairs and 8 polymorphisms).
Special statistical methods were adopted to accommodate
he higher number of polymorphisms in the genetic associ-
tion study, which included haplotype analysis (44,45),
ultifactor dimensionality reduction (46), and multilocus
enotype disequilibrium tests (47,48).
We genotyped angiotensin-converting enzyme gene I/D
olymorphism and T174M, M235T, G-6A, A-20C,
-152A, and G-217A polymorphisms of the angiotensino-
en gene as well as A1166C polymorphism of the angio-
ensin II type I receptor gene. We demonstrated that the
requencies of M235, G-6, and G-217 alleles in the angio-
ensinogen gene were significantly higher in AF patients
han in matched control subjects. The ORs for AF were 2.5
95% CI: 1.7 to 3.3) with M235/M235 plus M235/T235
enotype, 3.3 (95% CI: 1.3 to 10.0) with G-6/G-6 geno-
ype, and 2.0 (95% CI: 1.3 to 2.5) with G-217/G-217
enotype. Furthermore, significant gene-gene interactions
ere detected by the multifactor-dimensionality reduction
ethod and multilocus genotype disequilibrium tests. In
nother substudy, instead of using an individually matched
esign, a regression approach was used to evaluate the
ndependent effects of genetic factors while adjusting for the
onfounding effects of nongenetic factors (45).
Regarding their functional significance, polymorphisms
n the RAS genes may affect the serum angiotensin II level.
n addition to the profibrotic effect on the atrium (39), our wroup (49) also found that angiotensin II augments L-type
alcium current and calcium transient through increasing
he expression of the pore-forming 1C-subunit of L-type
alcium channel. Using a computer simulation model, it has
een demonstrated that increased L-type calcium current
lays a critical role in induction of dynamic spatial disper-
ions of repolarization in the atrium, which causes conduc-
ion block, re-entry, and initiation of AF (50). However, it
as yet to be demonstrated that polymorphisms of the RAS
enes promote AF via alterations of atrial angiotensin II
evels. Therefore, the possibility that angiotensin II pro-
otes AF through increasing L-type calcium current and
alcium overload remains speculative. More studies are
arranted to elucidate whether there is a mechanistic link
etween the observed association of RAS gene polymor-
hisms and AF.
onnexin-40 gene. Juang et al. (51) also reported an
ssociation between polymorphisms in the proximal pro-
oter region of connexin-40 gene with nonfamilial AF.
onnexin-40 plays an important role in electrical coupling
etween atrial myocytes. In this study, there were 173 AF
nd 232 control subjects, each with similar baseline charac-
eristics, including the percentage of patients with valvular
eart disease and similar mean left ventricular ejection
raction. The researchers found that the frequency of
onnexin-40 gene proximal promoter haplotype (44A,
71G) was significantly higher in the AF group than in the
ontrol group (OR: 1.51; 95% CI: 1.13 to 2.04; p  0.006).
uang et al. (51) also performed functional studies, demon-
trating that the (44A,71G) promoter haplotype was
ssociated with a lower promoter activity by luciferase assay.
urthermore, Firouzi et al. (52), using electrophoretic mo-
ility shift and luciferase reporter assays, showed that Sp1
nd GATA4 are important regulators of human connexin-40
ene transcription and that the 44G-to-A polymorphism
egatively affects the promoter regulation by the transcrip-
ion factors Sp1 and GATA4. This result indicates that
enetic variants in the connexin-40 gene may cause a
ecrease of connexin-40 expression. It is speculated that
ecreased connexin expression may impair electrical cou-
ling between atrial myocytes and create conduction heter-
geneity, which may provide the substrate for AF.
Recently, somatic mutations in the connexin-40 gene
ere found in atrial tissue specimens, but not in lympho-
ytes, from patients with lone AF. Gollob et al. (53)
equenced human connexin-40 gene from genomic DNA
solated from surgically resected atrial tissue and peripheral
ymphocytes from 15 patients with lone AF. Identified
utations were transfected into a gap-junction-deficient cell
ine to assess their functional effects on protein transport
nd intercellular electrical coupling. Four novel heterozy-
ous missense mutations, P88S (in 2 subjects), M163V (in
subject), G38D (in 1 subject), and A96S (in 1 subject),
ere identified. Three variants, P88S, M163V, and G38D,
ere found only in the atrial tissue specimens, but not in the
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Genetics of Atrial Fibrillation July 22, 2008:241–50ymphocytes, indicating a somatic source of the genetic
efects. One variant, A96S, was detected in both atrial
issue and lymphocytes, suggesting a germ-line origin.
nalysis of the expression of mutant proteins revealed
mpaired intracellular transport or reduced intercellular
lectrical coupling in P88S, G38D, and A96S variants.
hese results suggest that in addition to traditionally con-
idered germ-line mutations or variants, somatic mutations
lso play an important role in predisposition to common
iseases such as AF.
enes related to inflammation. Fatini et al. (31), in
ddition to the minK S38G polymorphism, also studied
NPs in the endothelial nitric oxide synthase gene
eNOS), which plays an important role in antioxidation
nd inflammation. They found that the eNOS 786C
llele weakly influenced the risk of nonvalvular AF.
owever, the contemporaneous presence of minK 38G
nd eNOS 786C alleles synergistically increased the
redisposition to nonvalvular AF (OR: 2.11; 95% CI:
.48 to 3.02; p  0.0001; OR: 2.58; 95% CI: 1.37 to
.88; p  0.003; OR: 3.08; 95% CI: 1.49 to 6.33; p 
.002; according to dominant, recessive, and additive
odels, respectively). Bedi et al. (54) also reported an
ssociation of the eNOS G894T polymorphism (OR: 3.2;
5% CI: 1.7 to 6.2; p  0.001; for GG genotype) with
F in 340 unselected unrelated patients with congestive
eart failure. However, they found no association of
NOS gene T-786C polymorphism with AF in their heart
ailure population. No functional data were available in
hese studies.
Recently, Kato et al. (55) studied 196 subjects with
hronic lone AF and 873 control subjects, and genotyped
0 polymorphisms of 32 candidate genes by a method
hat combines the polymerase chain reaction and
equence-specific oligonucleotide probes with suspension
rray technology. After multivariable logistic regression
nalysis with adjustment for age, gender, body mass
ndex, prevalence of smoking, hypertension, diabetes
ellitus, and hypercholesterolemia, the C-1306T poly-
orphism of the matrix metalloproteinase-2 gene (MMP2)
nd the A-592C polymorphism of the interleukin-10
ene (IL10) were significantly associated with the prev-
lence of AF. The T-allele of the MMP2 polymorphism
nd the C-allele of the IL10 polymorphism were, respec-
ively, a risk factor for and a protective factor against AF.
here were also no functional data available in this study.
In summary, these observations suggest that some form of
enetic control exists in the pathogenesis of the more
ommon type of AF. It is important to recognize that most
f these studies had small sample sizes and used a case-
ontrol design, making the results sensitive to the methods
sed to adjust for confounding effects and differences in the
opulation histories. However, these data are promising and
ay help to clarify why some people develop AF and otherso not in the general population. outure Aspects
he results of genetic studies of AF may provide insights
nto the mechanism of AF. For familial AF, most of the
dentified genes encode for ionic channel subunits. In these
amilies, AF is a presentation of a channelopathy. The
utations of these genes may result in a shorter atrial
efractory period, which facilitates the maintenance of
ultiple re-entries. For those families with the absence of
on channel mutation or those in which the responsible
enes have not been identified, the mechanism of AF is
nknown. Regarding the mechanism of nonfamilial or
ommon AF, in addition to the ionic current changes,
onduction delay and block related to atrial fibrosis, inflam-
ation, and altered expression of connexin facilitate the
nitiation and maintenance of multiple re-entries.
With the current availability of abundant genome-wide
NP markers, dissection of the underlying genetic loci for
F is possible. Recently, Gudbjartsson et al. (56) performed
genome-wide association scan, with the use of the Illu-
ina Hap300 BeadChip (San Diego, California) (316,515
NPs) in a sample of 550 patients with AF and/or atrial
utter and 4,476 control subjects from Iceland. This was
ollowed by replication studies in additional samples from
he Icelandic (2,251 case and 13,238 control subjects),
wedish (143 case and 738 control subjects), U.S. (636 case
nd 804 control subjects) and Chinese (333 case and 2,836
ontrol subjects) populations. They found a strong associa-
ion between 2 sequence variants on chromosome 4q25
rs2200733 and rs10033464) and AF in the European-
escent populations. The risk of AF increased by 1.72 and
.39 per copy, respectively. The association with the stron-
er variant was replicated in the Chinese population, where
he risk of AF was increased by 1.42 per copy. There is no
nown gene present in the haplotype block containing the 2
equence variants. The closest genes located in the adjacent
pstream haplotype block are the PITX2 and ENPEP
enes. The protein encoded by the PITX2 (paired-like
omeodomain transcription factor-2) gene is important in
ardiac development by directing the asymmetric morpho-
enesis of the heart. The protein encoded by the ENPEP
ene is an aminopeptidase responsible for the breakdown of
ngiotensin II in the vascular endothelium. Whether PITX2
r ENPEP is truly the responsible gene and the yet to be
escribed functional mechanism underlying these mutations
arrants further study.
Based upon a pharmacogenetic point of view (57), genetic
tudies may also help determine which patients may benefit
ost from the nonchannel blocking agents. For example,
AS gene polymorphisms in patients with AF may deter-
ine their response to angiotensin-converting enzyme in-
ibitor therapy (58). It is also possible that variations in
enes encoding for ionic channels may also identify high-
isk patients who are susceptible to the potential side effects
f channel-blocking antiarrhythmic drugs (59).
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July 22, 2008:241–50 Genetics of Atrial FibrillationHowever, many challenges are present, especially in the
tudies with a case-control design. Care must be taken to
void false-positive or false-negative results, including: 1) a
ery clear definition of the phenotypes, such as the attack
ype (paroxysmal, persistent, or chronic AF), family history
familial or nonfamilial), and underlying cardiovascular
iseases or nongenetic factors (AF with underlying heart
isease or lone AF); 2) use of a homogenous population
ith the same genetic background or ethnicity; 3) a large
ample size with adequate power; 4) correction for p values
n the context of multiple testing for association; 5) methods
o adjust the confounding effects from environmental fac-
ors; 6) evaluation of gene– gene or gene– environment
nteractions; 7) choice of SNPs or genes with functional
ignificance or a mechanistic links to the disease mechanism;
nd 8) association that is replicated or confirmed in other
tudies, especially in different ethnic populations. These ele-
ents are essential when performing a genetic association
tudy and necessary to allow definite conclusions.
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